211 related articles for article (PubMed ID: 32402336)
1. Vertical transmission of ALV from ALV-J positive parents caused severe immunosuppression and significantly reduced marek's disease vaccine efficacy in three-yellow chickens.
Wang P; Lin L; Shi M; Li H; Gu Z; Li M; Gao Y; Teng H; Mo M; Wei T; Wei P
Vet Microbiol; 2020 May; 244():108683. PubMed ID: 32402336
[TBL] [Abstract][Full Text] [Related]
2. Endogenous Avian Leukosis Virus in Combination with Serotype 2 Marek's Disease Virus Significantly Boosted the Incidence of Lymphoid Leukosis-Like Bursal Lymphomas in Susceptible Chickens.
Mays JK; Black-Pyrkosz A; Mansour T; Schutte BC; Chang S; Dong K; Hunt HD; Fadly AM; Zhang L; Zhang H
J Virol; 2019 Dec; 93(23):. PubMed ID: 31554689
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of an adventitious avian leukosis virus isolated from commercial Marek's disease vaccines.
Fadly A; Silva R; Hunt H; Pandiri A; Davis C
Avian Dis; 2006 Sep; 50(3):380-5. PubMed ID: 17039837
[TBL] [Abstract][Full Text] [Related]
4. Marek's disease virus as a CRISPR/Cas9 delivery system to defend against avian leukosis virus infection in chickens.
Liu Y; Xu Z; Zhang Y; Yu M; Wang S; Gao Y; Liu C; Zhang Y; Gao L; Qi X; Cui H; Pan Q; Li K; Wang X
Vet Microbiol; 2020 Mar; 242():108589. PubMed ID: 32122593
[TBL] [Abstract][Full Text] [Related]
5. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
[TBL] [Abstract][Full Text] [Related]
6. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
[TBL] [Abstract][Full Text] [Related]
7. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
Buscaglia C; Nervi P; Risso M
Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Viral Replication of Marek's Disease Virus and Avian Leukosis Virus Subgroup J is Responsible for the Enhanced Pathogenicity in the Superinfection of Chickens.
Zhou J; Zhao GL; Wang XM; Du XS; Su S; Li CG; Nair V; Yao YX; Cheng ZQ
Viruses; 2018 May; 10(5):. PubMed ID: 29783672
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Marek's Disease Virus as a Vector-Based Vaccine against Avian Leukosis Virus Subgroup J in Chicken.
Liu Y; Li K; Gao Y; Gao L; Zhong L; Zhang Y; Liu C; Zhang Y; Wang X
Viruses; 2016 Nov; 8(11):. PubMed ID: 27827933
[TBL] [Abstract][Full Text] [Related]
12. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF
Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
[TBL] [Abstract][Full Text] [Related]
14. Recombinant subgroup B avian leukosis virus combined with the subgroup J env gene significantly increases its pathogenicity.
Li Q; Wang P; Li M; Lin L; Shi M; Li H; Deng Q; Teng H; Mo M; Wei T; Wei P
Vet Microbiol; 2020 Nov; 250():108862. PubMed ID: 33007608
[TBL] [Abstract][Full Text] [Related]
15. Avian oncogenic virus differential diagnosis in chickens using oligonucleotide microarray.
Wang LC; Huang D; Pu CE; Wang CH
J Virol Methods; 2014 Dec; 210():45-50. PubMed ID: 25286179
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of a recombinant Marek's disease virus lacking the meq oncogene and evaluation on its immune efficacy against Marek's disease virus.
Sun P; Cui N; Liu L; Su S; Cheng Z; Chen R; Li Y; Cui Z
Poult Sci; 2020 Apr; 99(4):1939-1945. PubMed ID: 32241474
[TBL] [Abstract][Full Text] [Related]
17. Vertical transmission of avian leukosis virus subgroup J (ALV-J) from hens infected through artificial insemination with ALV-J infected semen.
Li Y; Cui S; Li W; Wang Y; Cui Z; Zhao P; Chang S
BMC Vet Res; 2017 Jun; 13(1):204. PubMed ID: 28662658
[TBL] [Abstract][Full Text] [Related]
18. Experimental infection with avian leukosis virus isolated from Marek's disease vaccines.
Zavala G; Cheng S
Avian Dis; 2006 Jun; 50(2):232-7. PubMed ID: 16863073
[TBL] [Abstract][Full Text] [Related]
19. Suspension culture of Marek's disease virus and evaluation of its immunological effects.
Wen L; Zhang A; Li Y; Lai H; Li H; Luo Q; Jin S; Chen R
Avian Pathol; 2019 Jun; 48(3):183-190. PubMed ID: 30518239
[TBL] [Abstract][Full Text] [Related]
20. Molecular indications for in vivo integration of the avian leukosis virus, subgroup J-long terminal repeat into the Marek's disease virus in experimentally dually-infected chickens.
Davidson I; Borenshtain R; Kung HJ; Witter RL
Virus Genes; 2002 Mar; 24(2):173-80. PubMed ID: 12018709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
